KR102489680B1 - 여주 분말을 주성분으로 하는 건강식품 조성물 - Google Patents
여주 분말을 주성분으로 하는 건강식품 조성물 Download PDFInfo
- Publication number
- KR102489680B1 KR102489680B1 KR1020220015953A KR20220015953A KR102489680B1 KR 102489680 B1 KR102489680 B1 KR 102489680B1 KR 1020220015953 A KR1020220015953 A KR 1020220015953A KR 20220015953 A KR20220015953 A KR 20220015953A KR 102489680 B1 KR102489680 B1 KR 102489680B1
- Authority
- KR
- South Korea
- Prior art keywords
- bitter gourd
- powder
- extract
- dried
- food composition
- Prior art date
Links
- 244000302512 Momordica charantia Species 0.000 title claims abstract description 82
- 235000009811 Momordica charantia Nutrition 0.000 title claims abstract description 80
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 235000013402 health food Nutrition 0.000 title claims abstract description 17
- 239000000284 extract Substances 0.000 title claims description 33
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims abstract description 71
- 239000000843 powder Substances 0.000 claims abstract description 44
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 241000533293 Sesbania emerus Species 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 241000218645 Cedrus Species 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241000219122 Cucurbita Species 0.000 claims description 6
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 6
- 235000003283 Pachira macrocarpa Nutrition 0.000 claims description 6
- 235000014364 Trapa natans Nutrition 0.000 claims description 6
- 235000009165 saligot Nutrition 0.000 claims description 6
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 240000001085 Trapa natans Species 0.000 claims description 4
- 244000300264 Spinacia oleracea Species 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 15
- 230000003178 anti-diabetic effect Effects 0.000 abstract description 11
- 239000003472 antidiabetic agent Substances 0.000 abstract description 6
- 230000003472 neutralizing effect Effects 0.000 abstract description 5
- 230000001953 sensory effect Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 description 18
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- 244000298903 Basella rubra Species 0.000 description 8
- 235000009380 Basella rubra Nutrition 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 244000228451 Stevia rebaudiana Species 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 230000003914 insulin secretion Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241000219109 Citrullus Species 0.000 description 3
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ODBRNZZJSYPIDI-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-6-C-glucopyranosylflavone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-UHFFFAOYSA-N 0.000 description 2
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 2
- 241000219315 Spinacia Species 0.000 description 2
- WJJFWGUVMIUWGG-UHFFFAOYSA-N Stereolensin Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O WJJFWGUVMIUWGG-UHFFFAOYSA-N 0.000 description 2
- 241001083492 Trapa Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229930185803 charantin Natural products 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 230000000225 effect on diabetes Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- -1 flavicarpa Natural products 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- UYJGIAWJIRZBNU-UHFFFAOYSA-N isoorientin Natural products OCC1OC(C(O)C(O)C1O)c2cc(O)c(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4 UYJGIAWJIRZBNU-UHFFFAOYSA-N 0.000 description 2
- ODBRNZZJSYPIDI-VJXVFPJBSA-N isoorientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-VJXVFPJBSA-N 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 1
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 1
- 108010018763 Biotin carboxylase Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- XDJJVCAXVCPAOA-UHFFFAOYSA-N Lucenin 1 Natural products OCC1OC(Oc2c(O)c(C3OCC(O)CC3O)c(O)c4C(=O)C=C(Oc24)c5ccc(O)c(O)c5)C(O)C(O)C1O XDJJVCAXVCPAOA-UHFFFAOYSA-N 0.000 description 1
- ZLPSOQFIIQIIAX-HUCDLMPTSA-N Lucenin 2 Natural products O=C1c2c(O)c([C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)c(O)c([C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)c2OC(c2cc(O)c(O)cc2)=C1 ZLPSOQFIIQIIAX-HUCDLMPTSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 1
- 241000218996 Passiflora Species 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 241000218995 Passifloraceae Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- FIAAVMJLAGNUKW-UHFFFAOYSA-N UNPD109131 Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C(C2C(C(O)C(O)C(CO)O2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O FIAAVMJLAGNUKW-UHFFFAOYSA-N 0.000 description 1
- FIAAVMJLAGNUKW-CRLPPWHZSA-N Vicenin 2 Natural products O=C1c2c(O)c([C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)c(O)c([C@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)c2OC(c2ccc(O)cc2)=C1 FIAAVMJLAGNUKW-CRLPPWHZSA-N 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- FIAAVMJLAGNUKW-VQVVXJKKSA-N isovitexin 8-C-beta-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O FIAAVMJLAGNUKW-VQVVXJKKSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLPSOQFIIQIIAX-VQVVXJKKSA-N lucenin-2 Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ZLPSOQFIIQIIAX-VQVVXJKKSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- CSNXTSWTBUEIJB-UHFFFAOYSA-N vicenin-II Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C(OC2C(C(O)C(O)C(CO)O2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O CSNXTSWTBUEIJB-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/15—General methods of cooking foods, e.g. by roasting or frying using wave energy, irradiation, electrical means or magnetic fields, e.g. oven cooking or roasting using radiant dry heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
구분 | 냄새 | 맛 | 외관 | 기호도 |
실시예 1 | 5.9 | 5.8 | 5.1 | 5.8 |
실시예 2 | 6.8 | 7.1 | 5.5 | 7.0 |
실시예 3 | 7.0 | 7.0 | 5.4 | 7.0 |
실시예 4 | 7.3 | 7.2 | 5.3 | 7.2 |
비교예 1 | 4.8 | 3.5 | 5.1 | 3.8 |
구분 | 혈당 강하(mg/dl) |
실시예 1 | 30 |
실시예 2 | 41 |
실시예 3 | 33 |
실시예 4 | 37 |
비교예 1 | 28 |
Claims (6)
- 여주(Momordica charantia L) 분말, 스테비아 분말, 말라바시금치(Malaba Spinach) 추출물 및 백향과 껍질 추출물을 유효성분으로 포함하되,
상기 여주 분말 100중량부에 대하여 스테비아 분말 1~6중량부, 말라바시금치(Malaba Spinach) 추출물 10~20중량부 및 백향과 껍질 추출물 10~20중량부를 포함하고,
상기 여주 분말은,
건여주를 준비하는 단계;
상기 건여주와 커피생두를 혼합하는 단계;
상기 혼합된 혼합물을 150~200℃에서 10~30분간 로스팅하는 단계;
상기 로스팅된 혼합물을 20~30℃에서 1~5시간 숙성하는 단계;
상기 숙성된 혼합물로부터 건여주를 분리하는 단계;
상기 분리된 건여주에 물을 가하여 추출, 여과하고 이를 건조하는 단계;를 포함하여 제조되는 건강식품 조성물.
- 삭제
- 삭제
- 삭제
- 제1항에 있어서,
상기 건여주와 커피생두를 혼합하는 단계에서,
마름열매를 더 혼합하는 것을 특징으로 하는 건강식품 조성물.
- 제5항에 있어서,
상기 건여주, 커피생두 및 마름열매를 1:0.1~0.3:0.1~0.3 중량비로 혼합하는 것을 특징으로 하는 건강식품 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220015953A KR102489680B1 (ko) | 2022-02-08 | 2022-02-08 | 여주 분말을 주성분으로 하는 건강식품 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220015953A KR102489680B1 (ko) | 2022-02-08 | 2022-02-08 | 여주 분말을 주성분으로 하는 건강식품 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102489680B1 true KR102489680B1 (ko) | 2023-01-18 |
Family
ID=85106579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220015953A KR102489680B1 (ko) | 2022-02-08 | 2022-02-08 | 여주 분말을 주성분으로 하는 건강식품 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102489680B1 (ko) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08289759A (ja) * | 1995-04-25 | 1996-11-05 | Ikedachiyou | 菱の実の香味抽出用粉体、菱の実の香味抽出方法および菱の実のリキュールの製造方法 |
KR20040010751A (ko) * | 2001-06-21 | 2004-01-31 | 교와 핫꼬 고교 가부시끼가이샤 | 식물체 분말 함유 식물 추출물의 제조 방법 |
JP2005087184A (ja) * | 2003-09-12 | 2005-04-07 | Tadashi Otake | ステビア由来成分含有飲食物及びその製造方法 |
KR20140089292A (ko) * | 2013-07-29 | 2014-07-14 | 이건종 | 여주 추출물을 주성분으로 하는 건강식품 조성물 및 그 제조방법 |
KR101520860B1 (ko) | 2014-10-21 | 2015-05-15 | 주식회사 아이웰 | 여주를 주원료로 한 당뇨 예방 및 개선용 기능성 식품 제조방법 |
KR20160006984A (ko) * | 2014-07-10 | 2016-01-20 | 주식회사 옵스 | 여주혼합커피의 제조방법 |
KR101688090B1 (ko) | 2016-01-15 | 2016-12-21 | 강원대학교산학협력단 | 돼지감자 추출물, 미강 추출물, 오미자 추출물, 여주 추출물을 함유하는 항당뇨 조성물 |
KR20180102237A (ko) * | 2017-03-06 | 2018-09-17 | 조선대학교산학협력단 | 여주 액상 차의 고미 개선 방법 및 이를 이용한 고미 개선 여주 액상 차의 제조방법 |
-
2022
- 2022-02-08 KR KR1020220015953A patent/KR102489680B1/ko active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08289759A (ja) * | 1995-04-25 | 1996-11-05 | Ikedachiyou | 菱の実の香味抽出用粉体、菱の実の香味抽出方法および菱の実のリキュールの製造方法 |
KR20040010751A (ko) * | 2001-06-21 | 2004-01-31 | 교와 핫꼬 고교 가부시끼가이샤 | 식물체 분말 함유 식물 추출물의 제조 방법 |
JP2005087184A (ja) * | 2003-09-12 | 2005-04-07 | Tadashi Otake | ステビア由来成分含有飲食物及びその製造方法 |
KR20140089292A (ko) * | 2013-07-29 | 2014-07-14 | 이건종 | 여주 추출물을 주성분으로 하는 건강식품 조성물 및 그 제조방법 |
KR20160006984A (ko) * | 2014-07-10 | 2016-01-20 | 주식회사 옵스 | 여주혼합커피의 제조방법 |
KR101520860B1 (ko) | 2014-10-21 | 2015-05-15 | 주식회사 아이웰 | 여주를 주원료로 한 당뇨 예방 및 개선용 기능성 식품 제조방법 |
KR101688090B1 (ko) | 2016-01-15 | 2016-12-21 | 강원대학교산학협력단 | 돼지감자 추출물, 미강 추출물, 오미자 추출물, 여주 추출물을 함유하는 항당뇨 조성물 |
KR20180102237A (ko) * | 2017-03-06 | 2018-09-17 | 조선대학교산학협력단 | 여주 액상 차의 고미 개선 방법 및 이를 이용한 고미 개선 여주 액상 차의 제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0126431B1 (ko) | 혈당강하 효과가 있는 건강식품 조성물 | |
KR101719241B1 (ko) | 여주혼합추출물을 주재로 한 음료 및 그 제조방법 | |
KR102136052B1 (ko) | 허브추출물을 유효성분으로 하는 간기능보호용 조성물 및 이를 함유하는 음료 | |
US20200147166A1 (en) | Health supplement food for promotion of hair growth, mitigation and alleviation of hair loss, regulation of blood glucose, and alleviation and relief of gastric disorder symptoms | |
KR101134542B1 (ko) | 매실 추출액을 이용한 홍삼 정과 및 절편의 제조방법 | |
KR20180137174A (ko) | 발모 촉진, 탈모 완화 및 개선용 건강보조식품 | |
KR20030026939A (ko) | 구아바잎을 주성분으로한 당뇨병치료용, 비만개선용,노화방지용차의 효과적인 조성물 및 이를 함유한 건강식품 | |
KR102404589B1 (ko) | 천년초 액상액을 이용한 누룽지의 제조 방법 | |
KR102262551B1 (ko) | 닭가슴살을 이용한 죽의 제조방법 및 닭가슴살을 이용한 죽 조성물 | |
KR100894636B1 (ko) | 둥근마추출액을 함유한 음료의 제조방법 | |
KR101788253B1 (ko) | 고량강, 풀솜대 및 흑마늘을 유효성분으로 포함하는 남성 성기능 개선용 조성물 | |
CN105192235A (zh) | 一种罗汉果薄荷糖及其制作方法 | |
KR102127411B1 (ko) | 복합 천연 추출물을 함유하는 간기능 보호 및 숙취해소용 조성물 | |
KR102489680B1 (ko) | 여주 분말을 주성분으로 하는 건강식품 조성물 | |
KR101647917B1 (ko) | 초석잠 추출물을 포함하는 약재 추출액과 밤 약술 및 그 제조방법 | |
KR102491108B1 (ko) | 홍삼 조청 제조 방법 및 이를 이용해 제조된 홍삼 조청 | |
KR102309486B1 (ko) | 여주 및 뽕잎을 포함하는 당뇨병, 고혈압 예방 및 개선 작용 기능성 차의 제조방법 | |
KR102466759B1 (ko) | 멀꿀 함유 국수와 그 제조방법 | |
KR100649128B1 (ko) | 매실을 주재료로 한 건강식품 조성물의 제조방법 | |
KR102368446B1 (ko) | 당뇨병 예방 또는 치료용 조성물 | |
KR20230059991A (ko) | 홍삼, 대두추출액, 대두발효추출액을 포함하는 사포닌 기능성 액상차 및 그 제조방법 | |
KR101003463B1 (ko) | 아토피성 피부염 억제효능을 갖는 청국장 환(丸)의 제조방법 | |
KR101203790B1 (ko) | 머위 된장의 제조방법 및 그 방법으로 제조된 머위 된장 | |
KR101811227B1 (ko) | 구기자, 복분자, 오미자 추출물을 함유한 면역증진, 피로회복, 생리활성 및 해독작용을 위한 조성물 | |
KR102423746B1 (ko) | 꾸지뽕과 예덕나무 및 아마란스 성분을 함유하는 음료 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20220208 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20220216 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20220208 Patent event code: PA03021R01I Comment text: Patent Application |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20220412 Patent event code: PE09021S01D |
|
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20220822 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230112 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20230113 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |